EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Importance of Gut Microbiota in Patients with Inflammatory Bowel Disease

Natalia Ekstedt, Dominika Jamioł-Milc iD, Joanna Pieczyńska

Nutrients · 2024

DOI: 10.3390/nu16132092 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Nutrients, 2024. Verfasst von Natalia Ekstedt und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Human Nutrition and Metabolomics, Pomeranian Medical University in Szczecin, 71-460 Szczecin, Poland. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Dysbiosis, Inflammatory Bowel Diseases. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Inflammatory bowel diseases (IBDs), such as Crohn’s disease (CD) and ulcerative colitis (UC), are chronic diseases of the digestive system with a multifactorial and not fully understood etiology. There is research suggesting that they may be initiated by genetic, immunological, and lifestyle factors. In turn, all of these factors play an important role in the modulation of intestinal microflora, and a significant proportion of IBD patients struggle with intestinal dysbiosis, which leads to the conclusion that intestinal microflora disorders may significantly increase the risk of developing IBD. Additionally, in IBD patients, Toll-like receptors (TLRs) produced by intestinal epithelial cells and dendritic cells treat intestinal bacterial antigens as pathogens, which causes a disruption of the immune response, resulting in the development of an inflammatory process. This may result in the occurrence of intestinal dysbiosis, which IBD patients are significantly vulnerable to. In this study, we reviewed scientific studies (in particular, systematic reviews with meta-analyses, being studies with the highest level of evidence) regarding the microflora of patients with IBD vs. the microflora in healthy people, and the use of various strains in IBD therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal MicrobiomeDysbiosisInflammatory Bowel DiseasesHumansCrohn DiseaseProbioticsColitis, Ulcerative

Stichwörter der Autor:innen

Crohn’s diseaseinflammatory bowel diseasesmicrobiotaprobiotic strainsprobiotic therapyulcerative colitis

Autor:innen und Institutionen

  • Department of Human Nutrition and Metabolomics, Pomeranian Medical University in Szczecin, 71-460 Szczecin, Poland.
  • Department of Food Science and Dietetics, Wroclaw Medical University, Borowska 211, 50-556 Wrocław, Poland.

ORCID-Profile: Dominika Jamioł-Milc

Zitieren

APA

Ekstedt, N., Jamioł-Milc, D., & Pieczyńska, J. (2024). Importance of Gut Microbiota in Patients with Inflammatory Bowel Disease. Nutrients. https://doi.org/10.3390/nu16132092

Vancouver

Ekstedt N, Jamioł-Milc D, Pieczyńska J. Importance of Gut Microbiota in Patients with Inflammatory Bowel Disease. Nutrients. 2024. doi:10.3390/nu16132092

BibTeX
@article{Ekstedt2024,
  author = {Ekstedt, Natalia and Jamioł-Milc, Dominika and Pieczyńska, Joanna},
  title = {Importance of Gut Microbiota in Patients with Inflammatory Bowel Disease},
  journal = {Nutrients},
  year = {2024},
  doi = {10.3390/nu16132092}
}
Kostenlos starten →